新天地:富马酸亚铁原料药上市申请获批准

Core Viewpoint - The company, New World (301277), has received approval from the National Medical Products Administration for the raw material drug Ferrous Fumarate, which is used to prevent and treat iron deficiency anemia [1] Group 1 - The approval includes the issuance of the "Chemical Raw Material Drug Listing Application Approval Notice" for Ferrous Fumarate [1] - Ferrous Fumarate is an iron supplement that improves hemoglobin synthesis and alleviates symptoms related to anemia [1]